FC
TMO icon

Fairscale Capital’s Thermo Fisher Scientific TMO Stock Holding History

Fairscale Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.17M Sell
2,386
-41
-2% -$22.3K 0.81% 22
2025
Q4 		$1.41M Buy
2,427
+7
+0.3% +$3.96K 0.93% 21
2025
Q3 		$1.17M Hold
2,420
– – 0.81% 25
2025
Q2 		$1.13M Sell
2,420
-33
-1% -$13.8K 0.82% 25
2025
Q1 		$1.22M Buy
2,453
+13
+0.5% +$7.04K 1.1% 21
2024
Q4 		$1.27M Hold
2,440
– – 1.09% 21
2024
Q3 		$1.51M Sell
2,440
-35
-1% -$20.7K 1.32% 13
2024
Q2 		$1.37M Buy
+2,475
New +$1.42M 1.22% 15

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fairscale Capital's TMO Position: Q1 2026 in Review

Fairscale Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.7% in Q1 2026, selling an estimated $22.3K and leaving 2,386 shares worth $1.17M. The position accounts for 0.81% of the portfolio, ranked #22.

Fairscale Capital first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.51M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fairscale Capital held 2,386 shares of Thermo Fisher Scientific worth $1.17M as of Q1 2026.
  • Fairscale Capital sold 41 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.3K.
  • Thermo Fisher Scientific made up 0.81% of Fairscale Capital's portfolio in Q1 2026, its #22 holding.
  • Fairscale Capital first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Thermo Fisher Scientific position peaked at $1.51M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.